Bausch + Lomb Corporation BLCO.TO

BLCO.TO Company Overview

Bausch + Lomb Corporation is a global eye health company focused on the development, manufacturing, and commercialization of products that support vision care and ocular health. The company operates primarily within the ophthalmology and vision care industries, serving consumers, eye care professionals, hospitals, and surgical centers. Its core activities span vision correction, ocular pharmaceuticals, and ophthalmic surgical devices, positioning it as one of the few fully integrated eye health companies worldwide.

The company’s primary revenue drivers include contact lenses, lens care products, prescription ophthalmic pharmaceuticals, and surgical instruments used in cataract and refractive procedures. Bausch + Lomb Corporation traces its origins to 1853, when it was founded in Rochester, New York, and has evolved through decades of expansion, innovation, and ownership changes. Most recently, the company became an independent publicly traded entity in 2022 following its separation from its former parent, Bausch Health Companies Inc., allowing it to pursue a more focused strategy centered exclusively on eye health.